Future Innovations to Watch in the Cancer biomarker Market
The Cancer biomarker Market is on the brink of major innovations. Advances in artificial intelligence, machine learning, and big data analytics are enabling more accurate biomarker-based predictions.
Additionally, liquid biopsy and proteomic biomarkers are emerging as non-invasive methods for early cancer detection and monitoring. As research evolves, these technologies are expected to reshape cancer care worldwide.
Market Outlook: With a valuation of USD 15.9 billion in 2022, the market will grow to USD 27.8 billion by 2030, achieving a strong 9.8% CAGR.
1 View